Journal article icon

Journal article

DNA methylation signatures associated with cardiometabolic risk factors in children from India and The Gambia: results from the EMPHASIS study

Abstract:
BACKGROUND: The prevalence of cardiometabolic disease (CMD) is rising globally, with environmentally induced epigenetic changes suggested to play a role. Few studies have investigated epigenetic associations with CMD risk factors in children from low- and middle-income countries. We sought to identify associations between DNA methylation (DNAm) and CMD risk factors in children from India and The Gambia. RESULTS: Using the Illumina Infinium HumanMethylation 850 K Beadchip array, we interrogated DNAm in 293 Gambian (7-9 years) and 698 Indian (5-7 years) children. We identified differentially methylated CpGs (dmCpGs) associated with systolic blood pressure, fasting insulin, triglycerides and LDL-Cholesterol in the Gambian children; and with insulin sensitivity, insulinogenic index and HDL-Cholesterol in the Indian children. There was no overlap of the dmCpGs between the cohorts. Meta-analysis identified dmCpGs associated with insulin secretion and pulse pressure that were different from cohort-specific dmCpGs. Several differentially methylated regions were associated with diastolic blood pressure, insulin sensitivity and fasting glucose, but these did not overlap with the dmCpGs. We identified significant cis-methQTLs at three LDL-Cholesterol-associated dmCpGs in Gambians; however, methylation did not mediate genotype effects on the CMD outcomes. CONCLUSION: This study identified cardiometabolic biomarkers associated with differential DNAm in Indian and Gambian children. Most associations were cohort specific, potentially reflecting environmental and ethnic differences
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-9477-1564
More by this author
Role:
Author
ORCID:
0000-0002-9636-0144
More by this author
Role:
Author
ORCID:
0000-0002-0532-267X
More by this author
Role:
Author
ORCID:
0000-0002-6560-4230
More by this author
Role:
Author
ORCID:
0000-0003-0083-7487


More from this funder
Funder identifier:
10.13039/501100009053
Grant:
BT/IN/DBT-MRC/DFID/24/GRC/2015-16
More from this funder
Funder identifier:
10.13039/100010897
Grant:
MR/N006208/1
More from this funder
Funder identifier:
10.13039/501100000265
Grant:
mc-a760-5qx00
MR/M0051186/1
u105960371
U105960371
u123261351
mr/m01424x/1
u1232661351


Publisher:
BioMed Central
Journal:
Clinical Epigenetics More from this journal
Volume:
14
Issue:
1
Pages:
6-6
Article number:
6
Publication date:
2022-01-09
DOI:
EISSN:
1868-7083
ISSN:
1868-7075


Language:
English
Keywords:
Pubs id:
1494722
Local pid:
pubs:1494722
Source identifiers:
W4206266040
Deposit date:
2026-05-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP